124 related articles for article (PubMed ID: 22078454)
1. [Expression and clinical significance of Nrf2 in esophageal squamous cell carcinoma].
Mao JT; Tangsakar E; Shen H; Wang ZQ; Zhang MX; Chen JX; Zhang G; Wang JS
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 Nov; 27(11):1231-3. PubMed ID: 22078454
[TBL] [Abstract][Full Text] [Related]
2. [Clinical significance of abnormal expression of Aurora-A in human esophageal squamous cell carcinoma with or without lymph node metastasis].
Shi J; Xue LY; Yin N; Lu J; Fu M; Dong LJ; Shao SJ; Tong T; Zhan QM
Zhonghua Zhong Liu Za Zhi; 2010 Oct; 32(10):748-51. PubMed ID: 21163064
[TBL] [Abstract][Full Text] [Related]
3. Expression of lysyl oxidase is correlated with lymph node metastasis and poor prognosis in esophageal squamous cell carcinoma.
Sakai M; Kato H; Sano A; Tanaka N; Inose T; Kimura H; Sohda M; Nakajima M; Kuwano H
Ann Surg Oncol; 2009 Sep; 16(9):2494-501. PubMed ID: 19526206
[TBL] [Abstract][Full Text] [Related]
4. [Expression and clinical significance of PI3K in esophageal squamous cell carcinoma].
Zhang Y; Liu YP; Du K; Wang H; Wang XL
Zhonghua Zhong Liu Za Zhi; 2011 Aug; 33(8):594-8. PubMed ID: 22325219
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance of detecting mucin 1 mRNA in diagnosing occult lymph node micrometastasis in esophageal cancer patients.
Liu XY; Chen G; Wang Z; Liu FY
Ai Zheng; 2007 Feb; 26(2):194-9. PubMed ID: 17298752
[TBL] [Abstract][Full Text] [Related]
6. [Expression and clinical significance of COX-2, p-Stat3, and p-Stat5 in esophageal carcinoma].
Liu JR; Wang Y; Zuo LF; Li FL; Wang Y; Liu JL
Ai Zheng; 2007 May; 26(5):458-62. PubMed ID: 17672932
[TBL] [Abstract][Full Text] [Related]
7. [Lymphatic metastasis intensity of and lymphadenectomy for thoracic esophageal squamous cell carcinoma].
Lu ZM; Zhang H; Wang MH; Cui DH; Yang YQ; Huang HZ
Ai Zheng; 2006 May; 25(5):604-8. PubMed ID: 16687083
[TBL] [Abstract][Full Text] [Related]
8. [Significance and expression of vascular endothelial growth factor-C (VEGF-C) in esophageal squamous carcinoma and glioma].
Pang XH; Tian H; Liu ZY; Li SM; Liu ST; Tian GP
Ai Zheng; 2003 Nov; 22(11):1166-9. PubMed ID: 14613645
[TBL] [Abstract][Full Text] [Related]
9. Vascular endothelial growth factor expression predicts outcome and lymph node metastasis in squamous cell carcinoma of the esophagus.
Shih CH; Ozawa S; Ando N; Ueda M; Kitajima M
Clin Cancer Res; 2000 Mar; 6(3):1161-8. PubMed ID: 10741747
[TBL] [Abstract][Full Text] [Related]
10. [Histopathological and immunohistochemical evaluation of lymph node metastasis in superficial esophageal cancer--with reference to the expression of E-cadherin and alpha-catenin].
Tamura S; Shiozaki H; Kadowaki T; Inoue M; Oka H; Matsui S; Mori T
Nihon Geka Gakkai Zasshi; 1995 Aug; 96(8):550-6. PubMed ID: 7565577
[TBL] [Abstract][Full Text] [Related]
11. [Influence of number of removed lymph nodes on the TNM staging and survival in advanced esophageal carcinoma].
Chen LQ; Hu CY; Zhang HL; He M; Meng XL; Ping YM
Zhonghua Zhong Liu Za Zhi; 2007 Aug; 29(8):604-8. PubMed ID: 18210881
[TBL] [Abstract][Full Text] [Related]
12. [Analysis of the survival in patients after surgical resection of thoracic esophageal cancer].
Zhang HL; Liu RL; Shi YT; Wang ZC; Wang BH; Li YJ; Zhou LY; Ping YM
Zhonghua Zhong Liu Za Zhi; 2009 Jul; 31(7):541-5. PubMed ID: 19950705
[TBL] [Abstract][Full Text] [Related]
13. Relationship between the expression of adhesion molecules in primary esophageal squamous cell carcinoma and metastatic lymph nodes.
Takayama N; Arima S; Haraoka S; Kotho T; Futami K; Iwashita A
Anticancer Res; 2003; 23(6a):4435-42. PubMed ID: 14666731
[TBL] [Abstract][Full Text] [Related]
14. [VEGF-C mRNA expression and its relationship with clinicopathological parameters in esophageal squamous cell carcinoma].
Pan XF; Bao GL; Fang WT; Chen WH
Zhonghua Zhong Liu Za Zhi; 2008 Jun; 30(6):437-40. PubMed ID: 19024518
[TBL] [Abstract][Full Text] [Related]
15. Matrix metalloproteinases expression correlates with survival in patients with esophageal squamous cell carcinoma.
Gu ZD; Li JY; Li M; Gu J; Shi XT; Ke Y; Chen KN
Am J Gastroenterol; 2005 Aug; 100(8):1835-43. PubMed ID: 16086722
[TBL] [Abstract][Full Text] [Related]
16. Association of matrilysin-2 (MMP-26) expression with tumor progression and activation of MMP-9 in esophageal squamous cell carcinoma.
Yamamoto H; Vinitketkumnuen A; Adachi Y; Taniguchi H; Hirata T; Miyamoto N; Nosho K; Imsumran A; Fujita M; Hosokawa M; Hinoda Y; Imai K
Carcinogenesis; 2004 Dec; 25(12):2353-60. PubMed ID: 15333466
[TBL] [Abstract][Full Text] [Related]
17. Expression of PC cell-derived growth factor and vascular endothelial growth factor in esophageal squamous cell carcinoma and their clinicopathologic significance.
Chen XY; Li JS; Liang QP; He DZ; Zhao J
Chin Med J (Engl); 2008 May; 121(10):881-6. PubMed ID: 18706200
[TBL] [Abstract][Full Text] [Related]
18. Expression of CXCL12/CXCR4 and its correlation to prognosis in esophageal squamous cell carcinoma.
Wang DF; Lou N; Zeng CG; Zhang X; Chen FJ
Ai Zheng; 2009 Feb; 28(2):154-8. PubMed ID: 19550128
[TBL] [Abstract][Full Text] [Related]
19. Nrf2 is useful for predicting the effect of chemoradiation therapy on esophageal squamous cell carcinoma.
Kawasaki Y; Okumura H; Uchikado Y; Kita Y; Sasaki K; Owaki T; Ishigami S; Natsugoe S
Ann Surg Oncol; 2014 Jul; 21(7):2347-52. PubMed ID: 24599410
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathological significance of vascular endothelial growth factor-C and cyclooxygenase-2 in esophageal squamous cell carcinoma.
Byeon JS; Jung HY; Lee YJ; Lee D; Lee GH; Myung SJ; Yang SK; Hong WS; Kim JH; Min YI; Kim JS
J Gastroenterol Hepatol; 2004 Jun; 19(6):648-54. PubMed ID: 15151619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
